X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
gastroenterology & hepatology (54) 54
male (48) 48
female (46) 46
middle aged (42) 42
adult (38) 38
index medicus (36) 36
hepatitis c, chronic - drug therapy (22) 22
antiviral agents - therapeutic use (21) 21
prospective studies (21) 21
aged (20) 20
hepacivirus - genetics (20) 20
genotype (17) 17
hepatitis c virus (17) 17
gastroenterology and hepatology (16) 16
hepatitis c (16) 16
interferon-alpha - therapeutic use (16) 16
treatment outcome (16) 16
drug therapy, combination (14) 14
infection (14) 14
life sciences (14) 14
france (13) 13
hepatitis c, chronic - virology (13) 13
liver (13) 13
liver - pathology (13) 13
ribavirin (13) 13
therapy (13) 13
virus-infection (13) 13
cirrhosis (12) 12
ribavirin - therapeutic use (12) 12
hepatitis (11) 11
recombinant proteins (11) 11
rna, viral - blood (11) 11
viral load (11) 11
cohort studies (10) 10
virology (10) 10
analysis (9) 9
chronic hepatitis-c (9) 9
hepatitis c - drug therapy (9) 9
polyethylene glycols - therapeutic use (9) 9
abridged index medicus (8) 8
antiviral agents - administration & dosage (8) 8
antiviral agents - adverse effects (8) 8
biopsy (8) 8
digestive system diseases (8) 8
hcv (8) 8
hepatitis c, chronic - genetics (8) 8
interferon-alpha - administration & dosage (8) 8
liver cancer (8) 8
patients (8) 8
prevalence (8) 8
prognosis (8) 8
sustained virological response (8) 8
alanine transaminase - blood (7) 7
cancer (7) 7
health aspects (7) 7
hepacivirus - drug effects (7) 7
hepatitis c, chronic - pathology (7) 7
interferon (7) 7
interferon-alpha - adverse effects (7) 7
liver cirrhosis - virology (7) 7
polyethylene glycols (7) 7
predictive value of tests (7) 7
time factors (7) 7
virus diseases (7) 7
antiviral agents (6) 6
association (6) 6
follow-up studies (6) 6
france - epidemiology (6) 6
hepacivirus - isolation & purification (6) 6
hepatitis c - complications (6) 6
hepatitis c - diagnosis (6) 6
infectious diseases (6) 6
liver cirrhosis - pathology (6) 6
management (6) 6
multivariate analysis (6) 6
polyethylene glycols - adverse effects (6) 6
quality of life (6) 6
recombinant proteins - therapeutic use (6) 6
risk (6) 6
adolescent (5) 5
anrs co12 cirvir (5) 5
care and treatment (5) 5
efficacy (5) 5
genetic aspects (5) 5
hepatitis b (5) 5
hepatitis c - pathology (5) 5
hepatitis c, chronic - complications (5) 5
hepatology (5) 5
human health and pathology (5) 5
liver cirrhosis (5) 5
liver cirrhosis - complications (5) 5
medicine (5) 5
mortality (5) 5
peginterferon alpha-2a (5) 5
plus ribavirin (5) 5
polyethylene glycols - administration & dosage (5) 5
research (5) 5
retrospective studies (5) 5
ribavirin - administration & dosage (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


La Presse Medicale, ISSN 0755-4982, 06/2013, Volume 42, Issue 6, pp. 977 - 982
. This association allows a virological eradication in 55% of patients, all genotype and 40% of those infected with genotype 1, the most prevalent. were... 
Journal Article
Presse Medicale, ISSN 0755-4982, 2013, Volume 42, Issue 6, pp. 977 - 982
The current treatment of patients with chronic HCV infection since ten years is pegylated interferon combined with ribavirin. This association allows a... 
Journal Article
Hepatology, ISSN 0270-9139, 12/2012, Volume 56, Issue 6, pp. 2039 - 2050
Journal Article
Presse medicale (Paris, France : 1983), 06/2013, Volume 42, Issue 6 Pt 1, p. 977
Journal Article
Hepatology, ISSN 0270-9139, 09/2015, Volume 62, Issue 3, pp. 737 - 750
Journal Article
Hepatology, ISSN 0270-9139, 10/2016, Volume 64, Issue 4, pp. 1136 - 1147
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 10/2016, Volume 61, Issue 10, pp. 3072 - 3083
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 152, Issue 1, pp. 142 - 156.e2
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 04/2018, Volume 198, pp. 4 - 17
The objective was to examine the role of a sustained virological response (SVR) on major adverse cardiovascular events (MACEs) in patients with compensated... 
ETHNIC-DIFFERENCES | HEART-DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | VIRUS-INFECTION | RISK-FACTORS | MYOCARDIAL-INFARCTION | ANTIVIRAL TREATMENT | ANRS CO12 CIRVIR | EXTRAHEPATIC MANIFESTATIONS | PERIPHERAL ARTERIAL-DISEASE | MIXED CRYOGLOBULINEMIA | Immunohistochemistry | Predictive Value of Tests | Age Distribution | Prevalence | Prognosis | Humans | Middle Aged | Cardiovascular Diseases - therapy | Hepatitis C, Chronic - physiopathology | Male | Hepatitis C, Chronic - complications | Cardiovascular Diseases - epidemiology | Female | Retrospective Studies | France | Liver Function Tests | Severity of Illness Index | Cardiovascular Diseases - etiology | Risk Assessment | Antiviral Agents - therapeutic use | Liver Cirrhosis - complications | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Hepatitis C, Chronic - drug therapy | Liver Cirrhosis - virology | Liver Cirrhosis - pathology | Sex Distribution | Aged | Biopsy, Needle | Cohort Studies | Control | Hepatitis C | Analysis | Myocardial infarction | Heart | Heart attacks | Viremia | Liver | Viruses | Cardiovascular disease | Infections | Bilirubin | Family medical history | Multivariate analysis | Hepatitis | Body mass index | Liver cancer | Ischemia | Blood platelets | Atherosclerosis | Heart diseases | Hypertension | Cerebral infarction | Stroke | Level (quantity) | Mortality | Diabetes mellitus | Albumin | Principal components analysis | Serum albumin | Angina pectoris | Patients | Coronary artery disease | Ethnic factors | Cirrhosis | Biopsy | Coronary vessels | Infarction | Diabetes | Hepatitis C virus | Smoking
Journal Article
Gut, ISSN 0017-5749, 02/2017, Volume 66, Issue 2, pp. 330 - 341
Journal Article
Journal Article